Filing Details
- Accession Number:
- 0001209191-14-009097
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2014-02-11 16:12:44
- Reporting Period:
- 2014-02-07
- Filing Date:
- 2014-02-11
- Accepted Time:
- 2014-02-11 16:12:44
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1373707 | Tetraphase Pharmaceuticals Inc | TTPH | Pharmaceutical Preparations (2834) | 000000000 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1572000 | Charles David Lubner | 480 Arsenal St. Suite 110 Watertown MA 02472 | Svp And Cfo | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2014-02-07 | 34,482 | $0.87 | 57,028 | No | 4 | M | Direct | |
| Common Stock | Acquisiton | 2014-02-07 | 33,295 | $2.03 | 90,323 | No | 4 | M | Direct | |
| Common Stock | Acquisiton | 2014-02-07 | 20,614 | $2.03 | 110,937 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2014-02-07 | 9,928 | $14.22 | 101,009 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | M | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Employee Stock Option (right to buy) | Disposition | 2014-02-07 | 34,482 | $0.00 | 34,482 | $0.87 |
| Common Stock | Employee Stock Option (right to buy) | Disposition | 2014-02-07 | 33,295 | $0.00 | 33,295 | $2.03 |
| Common Stock | Employee Stock Option (right to buy) | Disposition | 2014-02-07 | 20,614 | $0.00 | 20,614 | $2.03 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 0 | 2019-09-10 | No | 4 | M | Direct | |
| 7,684 | 2020-06-27 | No | 4 | M | Direct | |
| 34,359 | 2022-06-05 | No | 4 | M | Direct |
Footnotes
- The exercise and sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 17, 2013.
- The price reported represents the weighted average sales price of shares sold in multiple transactions at prices ranging from $14.10 to $14.45 per share. The reporting person hereby undertakes, upon request of the staff of the U.S. Securities and Exchange Commission, the issuer, or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price.
- Fully vested.
- The option is vested as to 33,295 shares, with further vesting as to an additional 2,561 shares on 3/18/2014 and at the end of each successive three-month period until 9/18/2014.
- The option is vested as to 20,614 shares, with further vesting as to an additional 3,436 shares on 3/6/2014 and at the end of each successive three-month period until 6/6/2016.
Billionaire Hedge Funds
